• About us
• Contact

Advertisement

Organisation › Details

Nucleix (IL)

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS and PCR-based epigenetics, the Company’s pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Company’s non-invasive EpiCheck® platform delivers highly accurate and sensitive results, all while providing a seamless testing option for patients and the healthcare system. The Company is building an EpiCheck franchise, beginning with the Bladder EpiCheck® testing kit, marketed in Europe for bladder cancer recurrence. The Company is advancing a Lung EpiCheck test toward commercialization for high-risk individuals, while advancing additional tests for high-risk diseases. *

 

	Start	2021-04-07 existent
	Industry	liquid biopsy
	Industry 2	molecular diagnostics
	Person	Hibberd, Christopher (Chris) (Nucleix 202104 CEO before Astute Medical + Biosite Discovery)
	Region	Rehovot
	Country	Israel
	Street	3 Pekeris Street
	City	7670203 Rehovot
	Tel	+972-8-9161616
		Address record changed: 2021-08-18
Basic data	Employees	n. a.
		* Document for »About Section«: Nucleix. (4/7/21). "Press Release: Nucleix Secures $55 Million Funding Led by RA Capital Management and Additional Prominent Life Science Investors to Advance Lung EpiCheck® for Early Detection of Lung Cancer". San Diego, CA & Rehovot.
		Record changed: 2022-01-02

Advertisement

More documents for Nucleix (IL)

• [1] Nucleix. (4/7/21). "Press Release: Nucleix Secures $55 Million Funding Led by RA Capital Management and Additional Prominent Life Science Investors to Advance Lung EpiCheck® for Early Detection of Lung Cancer". San Diego, CA & Rehovot....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.